首页 | 本学科首页   官方微博 | 高级检索  
检索        

周剂量CPT-11治疗FOLFOX治疗失败的转移性结直肠癌
引用本文:张斌.周剂量CPT-11治疗FOLFOX治疗失败的转移性结直肠癌[J].医药论坛杂志,2009(4).
作者姓名:张斌
作者单位:夏邑县人民医院肿瘤科;
摘    要:目的观察和评价依立替康(CPT-11)联合5-FU/LV治疗FOLFOX治疗失败的转移性结直肠癌的疗效及不良反应。方法入组患者共34例为转移性结直肠癌,经草酸铂及5-FU/LV治疗失败后,予CPT-11 60mg/m2,LV100mg/m2,5-FU 500mg/m2,每周1次,连续3周,每4周重复。患者最多接受6个周期,每例至少2周期化疗后评价疗效。结果全组34病例均可评价。PR为5例,SD为17例,有效率14.7%(95%可信区间3.6%~34.4%),疾病控制率64.7%(95%可信区间46.8%~85.6%),平均TTP为3.5个月(范围1.5~7.5个月)。主要不良反应为白细胞减少,恶心呕吐,手足综合征及延迟性腹泻,其不良反应发生率分别为67.4%(23/34),61.8%(21/34),64.8%(22/34),38.2%(13/34),均无IV度不良反应。结论周剂量伊立替康联合5-FU/LV为草酸铂治疗失败的转移性结直肠癌挽救治疗方案,不良反应轻微,适合于曾经强烈化疗患者。

关 键 词:伊立替康  联合化疗  转移性结直肠癌  

Effect of Weekly Chemotherapy Based on CPT-11 on FOLFOX Failure in Patients with Metastasis Colorectal Cancer
ZHANG Bin Xiayi Peoplie's Hospital,Xiayi ,China.Effect of Weekly Chemotherapy Based on CPT-11 on FOLFOX Failure in Patients with Metastasis Colorectal Cancer[J].Journal of Medical Forum,2009(4).
Authors:ZHANG Bin Xiayi Peoplie's Hospital  Xiayi  China
Institution:ZHANG Bin Xiayi Peoplie's Hospital,Xiayi 476400,China
Abstract:Objective To evaluate the clinical efficacy and adverse effects of irinotecan(CPT-11) combined with 5-Fu /LV after FOLFOX failure in patients with metastasis colorectal cancer.Methods Total 34 patients with metastasis colorectal cancer,who were failed in being treated with platinum oxalate and 5-Fu /LV,received 4 week regimen: CPT-11 60mg/m2 ivgtt d1,8,15,LV 100mg/m2 ivgtt d1,8,15,5-FU 500mg/m2 ivgtt d1,8,15;a cycle was 28 days.The cycle was not more than six.Results Total 34 cases could evaluate efficacy,t...
Keywords:
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号